Genetic Engineering & Biotechnology News
Biopharmaceutical, COVID-19, Innovation
In February 2020, NIIMBL ran a three-day workshop, which included participants from the FDA, the U.S. National Institute of Standards and Technology, plus what Erickson describes as “distinguished leaders in manufacturing and process development from 14 major manufacturers and suppliers.”
In January 2021, a team of pharmaceutical experts...